MMP2 and cancer: Overall, our results indicate that, by inhibiting MMP-2 and -9 functions, deflamin impairs ECM remodeling through inhibition of collagen degradation and tumor angiogenesis, important processes for cancer progression, rather than having a direct action on cancer cell proliferation and apoptosis.